Mounting evidence has suggested that obesity-associated inflammation, so-called meta-inflammation, triggers glucose intolerance and type 2 diabetes by interrupting insulin signaling in insulin-target tissues [3, 4]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.